Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

• Minimal residual disease assessment following CD19‐targeted therapy in B‐cell precursor acute lymphoblastic leukemia using standardized 12‐color flow cytometry: A EuroFlow study

  2025 HemaSphere article Medicine Acute Lymphoblastic Leukemia research Open access

  6

  citations
• Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines

  2024 Leukemia article Medicine Acute Lymphoblastic Leukemia research Open access

  33

  citations
• Automated EuroFlow approach for standardized in-depth dissection of human circulating B-cells and plasma cells

  2023 Frontiers in Immunology article Immunology and Microbiology T-cell and B-cell Immunology Open access

  6

  citations
• Minimal residual disease assessment in B ‐cell precursor acute lymphoblastic leukemia by semi‐automated identification of normal hematopoietic cells: A EuroFlow study

  2023 Cytometry Part B Clinical Cytometry article Medicine Acute Lymphoblastic Leukemia research Open access

  12

  citations
• The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency: Daily practice performance in a tertiary university hospital

  2022 Frontiers in Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

  15

  citations
• Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome

  2022 Cancers article Medicine Acute Lymphoblastic Leukemia research Open access

  4

  citations
• Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach

  2022 British Journal of Dermatology article Medicine Cutaneous lymphoproliferative disorders research Open access

  38

  citations
• Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels

  2022 Cancers article Medicine Clinical Laboratory Practices and Quality Control Open access

  13

  citations
• Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study

  2021 British Journal of Haematology article Medicine Acute Lymphoblastic Leukemia research Open access

  18

  citations
• Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study

  2021 The Lancet Haematology article Medicine Acute Lymphoblastic Leukemia research Open access

  19

  citations
• Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination

  2021 Frontiers in Immunology article Immunology and Microbiology Bacterial Infections and Vaccines Open access

  24

  citations
• Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

  2021 Cancers article Medicine Multiple Myeloma Research and Treatments Open access

  18

  citations
• Improved Standardization of Flow Cytometry Diagnostic Screening of Primary Immunodeficiency by Software-Based Automated Gating

  2020 Frontiers in Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

  21

  citations
• Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

  2020 Modern Pathology article Medicine Acute Lymphoblastic Leukemia research Open access

  28

  citations

14 results